Cutler Group LP Citius Pharmaceuticals, Inc. Put Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Jan 18, 2022
SELL
$1.51 - $2.2 $4,228 - $6,160
-2,800 Reduced 13.46%
18,000 $24,000
Q3 2021

Oct 26, 2021
BUY
$1.74 - $2.6 $16,878 - $25,220
9,700 Added 87.39%
20,800 $23,000
Q2 2021

Jul 19, 2021
BUY
$1.51 - $4.23 $16,761 - $46,953
11,100 New
11,100 $11,000

Others Institutions Holding CTXR

# of Institutions
70
Shares Held
26.7M
Call Options Held
0
Put Options Held
0
View Full List

About Citius Pharmaceuticals, Inc.

CTXR Quotes by TradingView
  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $140M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email